Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 13.52%
2
Positive results in Dec 24
3
With ROE of 23.38%, it has a Attractive valuation with a 0.59 Price to Book Value
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
5
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.7%
0%
22.7%
6 Months
30.9%
0%
30.9%
1 Year
37.2%
0%
37.2%
2 Years
39.33%
0%
39.33%
3 Years
32.56%
0%
32.56%
4 Years
-12.18%
0%
-12.18%
5 Years
26.41%
0%
26.41%
Genertec Universal Medical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.59%
EBIT Growth (5y)
3.64%
EBIT to Interest (avg)
2.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
22.52%
Dividend Payout Ratio
30.05%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.68%
ROE (avg)
13.52%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.59
EV to EBIT
1.86
EV to EBITDA
1.60
EV to Capital Employed
0.51
EV to Sales
0.50
PEG Ratio
1.03
Dividend Yield
1.65%
ROCE (Latest)
27.20%
ROE (Latest)
23.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
15,409.80
14,101.50
9.28%
Operating Profit (PBDIT) excl Other Income
6,028.20
6,401.20
-5.83%
Interest
2,557.50
2,365.20
8.13%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,331.20
2,344.50
-0.57%
Operating Profit Margin (Excl OI)
354.90%
417.80%
-6.29%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 9.28% vs 17.26% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -0.57% vs 1.42% in Dec 2022
About Genertec Universal Medical Group Co., Ltd. 
Genertec Universal Medical Group Co., Ltd.
Finance
No Details Available.
Company Coordinates 
No Company Details Available






